FDA Pilot Program Eases Rules for Nicotine Pouch Makers 
Oil Prices Set for Steep Weekly Losses as Hormuz Deal Stalls 
Tabletop particle accelerator could transform medicine and materials science 
Trump Signs Executive Order to Boost AI Research in Childhood Cancer 
Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised 
AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback 
US Yen Intervention Unlikely to Deliver Lasting Recovery, Yardeni Says 
Trump Administration Releases New UFO Files and Apollo Mission Records 
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission 
US Dollar Near Two-Month Low as Markets Await Inflation Data 
Fungi are among the planet’s most important organisms — yet they continue to be overlooked in conservation strategies 
Goldman Sachs Sees US Stock Buybacks Outpacing Equity Issuance as AI Funding Rises 
Iran-Oman Near Strait of Hormuz Deal as Shipping Tensions Persist 
As the Black Summer megafires neared, people rallied to save wildlife and domestic animals. But it came at a real cost 
Treasury Wine Estates Shares Jump as U.S. Overhaul Lifts FY2026 Outlook 
Fertile land for growing vegetables is at risk — but a scientific discovery could turn the tide 
SK Geocentric Co. and textile and chemical materials maker Kolon Industries Inc. have commercially released a polybutylene adipate-co-terephthalate (PBAT)-based plastic that they developed jointly.
PBAT is used primarily for various one-off plastic bags and agricultural vinyl, which decomposes more than 90 percent within six months after being buried.
On the other hand, general plastic products take about 100 years to decompose naturally.
Kolon Industries' Gumi plant can produce 3,000 tons of PBAT per year.
SK Geocentric, a chemical affiliate of SK Innovation Co. and South Korea’s only producer of 1,4-butanediol, a main component of PBAT, will supply raw materials to Kolon Industries.
The annual production capacity is expected to be 60,000 tons by 2024.
They signed a strategic partnership in April and since then produced trial products and acquired related certificates before announcing the release of a commercial product.
